1-6 of 6
Ruby Leong
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma

Deepti Telaraja, Yvette L. Kasamon, Justin S. Collazo, Ruby Leong, Kun Wang, Ping Li, Elyes Dahmane, Yuching Yang, Justin Earp, Manuela Grimstein, Lisa R. Rodriguez, Marc R. Theoret, Nicole J. Gormley
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (1): 17–22.
https://doi.org/10.1158/1078-0432.CCR-23-1272
Published: 05 January 2024
View articletitled, FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma
Open the PDF for FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma in another window
Journal Articles

FDA Approval Summary: Oral Azacitidine for Continued Treatment of Adults with Acute Myeloid Leukemia Unable to Complete Intensive Curative Therapy

Emily Y. Jen, Xin Wang, Meng Li, Hongshan Li, Shwu-Luan Lee, Nina Ni, Donna Przepiorka, Jonathon Vallejo, Ruby Leong, Lian Ma, Brenda J. Gehrke, Sherita McLamore, Marc R. Theoret, R. Angelo de Claro
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (14): 2989–2993.
https://doi.org/10.1158/1078-0432.CCR-21-4525
Published: 15 July 2022
View articletitled, FDA Approval Summary: Oral Azacitidine for Continued Treatment of Adults with Acute Myeloid Leukemia Unable to Complete Intensive Curative Therapy
Open the PDF for FDA Approval Summary: Oral Azacitidine for Continued Treatment of Adults with Acute Myeloid Leukemia Unable to Complete Intensive Curative Therapy in another window
Journal Articles

FDA Approval Summary: Selumetinib for Plexiform Neurofibroma

Denise Casey, Suzanne Demko, Arup Sinha, Pallavi S. Mishra-Kalyani, Yuan-li Shen, Sachia Khasar, M. Anwar Goheer, Whitney S. Helms, Lili Pan, Yuan Xu, Jianghong Fan, Ruby Leong, Jiang Liu, Yuching Yang, Katherine Windsor, Mei Ou, Olen Stephens, Byeongtaek Oh, Gregory H. Reaman, Abhilasha Nair, Stacy S. Shord, Vishal Bhatnagar, Selena R. Daniels, Sharon Sickafuse, Kirsten B. Goldberg, Marc R. Theoret, Richard Pazdur, Harpreet Singh
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (15): 4142–4146.
https://doi.org/10.1158/1078-0432.CCR-20-5032
Published: 01 August 2021
View articletitled, FDA Approval Summary: Selumetinib for Plexiform Neurofibroma
Open the PDF for FDA Approval Summary: Selumetinib for Plexiform Neurofibroma in another window
Journal Articles

FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm

Emily Y. Jen, Xin Gao, Liang Li, Luning Zhuang, Natalie E. Simpson, Baikuntha Aryal, Rong Wang, Donna Przepiorka, Yuan Li Shen, Ruby Leong, Chao Liu, Christopher M. Sheth, Steven Bowen, Kirsten B. Goldberg, Ann T. Farrell, Gideon M. Blumenthal, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (3): 532–536.
https://doi.org/10.1158/1078-0432.CCR-19-2329
Published: 03 February 2020
View articletitled, FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
Open the PDF for FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm in another window
Includes: Supplementary data
Journal Articles

FDA Approval Summary: Glasdegib for Newly Diagnosed Acute Myeloid Leukemia

Kelly J. Norsworthy, Kunthel By, Sriram Subramaniam, Luning Zhuang, Pedro L. Del Valle, Donna Przepiorka, Yuan-Li Shen, Christopher M. Sheth, Chao Liu, Ruby Leong, Kirsten B. Goldberg, Ann T. Farrell, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (20): 6021–6025.
https://doi.org/10.1158/1078-0432.CCR-19-0365
Published: 15 October 2019
View articletitled, FDA Approval Summary: Glasdegib for Newly Diagnosed Acute Myeloid Leukemia
Open the PDF for FDA Approval Summary: Glasdegib for Newly Diagnosed Acute Myeloid Leukemia in another window
Includes: Supplementary data
Journal Articles

FDA Approval: Ceritinib for the Treatment of Metastatic Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer

Sean Khozin, Gideon M. Blumenthal, Lijun Zhang, Shenghui Tang, Margaret Brower, Emily Fox, Whitney Helms, Ruby Leong, Pengfei Song, Yuzhuo Pan, Qi Liu, Ping Zhao, Hong Zhao, Donghao Lu, Zhe Tang, Ali Al Hakim, Karen Boyd, Patricia Keegan, Robert Justice, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (11): 2436–2439.
https://doi.org/10.1158/1078-0432.CCR-14-3157
Published: 31 May 2015
View articletitled, FDA Approval: Ceritinib for the Treatment of Metastatic Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer
Open the PDF for FDA Approval: Ceritinib for the Treatment of Metastatic Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer in another window